Results 1 to 6 of 6

Thread: Wuhan Ultra Biohazard Lab Was Studying "The World's Most Dangerous Pathogens"

  1. #1
    Join Date
    May 2009
    Posts
    6,724

    Default Wuhan Ultra Biohazard Lab Was Studying "The World's Most Dangerous Pathogens"

    The Real Umbrella Corp: Wuhan Ultra Biohazard Lab Was Studying "The World's Most Dangerous Pathogens"


    by Tyler Durden
    Thu, 01/23/2020 - 14:10

    Now that not one but seven Chinese cities - including Wuhan, ground zero of the coronavirus epidemic - and collectively housing some 23 million people, are under quarantine...

    ... comparisons to the infamous Raccoon City from Resident Evil are coming in hot and heavy. And, since reality often tends to imitate if not art then certainly Hollywood, earlier today we jokingly asked if the Medical Research Institute at Wuhan University would end up being China's version of Umbrella Corp.

    As it turns out, it wasn't a joke, because moments ago it was brought to our attention that in February 2017, Nature penned an extensive profile of what it called the "Chinese lab poised to study world's most dangerous pathogens." The location of this BSL-4 rated lab? Why, Wuhan.
    A quick read of what this lab was meant to do, prompts the immediate question whether the coronavirus epidemic isn't a weaponized virus that just happened to escape the lab:
    The Wuhan lab cost 300 million yuan (US$44 million), and to allay safety concerns it was built far above the flood plain and with the capacity to withstand a magnitude-7 earthquake, although the area has no history of strong earthquakes. It will focus on the control of emerging diseases, store purified viruses and act as a World Health Organization ‘reference laboratory’ linked to similar labs around the world. “It will be a key node in the global biosafety-lab network,” says lab director Yuan Zhiming.
    The Chinese Academy of Sciences approved the construction of a BSL-4 laboratory in 2003, and the epidemic of SARS (severe acute respiratory syndrome) around the same time lent the project momentum. The lab was designed and constructed with French assistance as part of a 2004 cooperative agreement on the prevention and control of emerging infectious diseases. But the complexity of the project, China’s lack of experience, difficulty in maintaining funding and long government approval procedures meant that construction wasn’t finished until the end of 2014.
    The lab’s first project will be to study the BSL-3 pathogen that causes Crimean–Congo haemorrhagic fever: a deadly tick-borne virus that affects livestock across the world, including in northwest China, and that can jump to people.
    Future plans include studying the pathogen that causes SARS, which also doesn’t require a BSL-4 lab, before moving on to Ebola and the West African Lassa virus,
    What does BSL-4 mean?
    BSL-4 is the highest level of biocontainment: its criteria include filtering air and treating water and waste before they leave the laboratory, and stipulating that researchers change clothes and shower before and after using lab facilities. Such labs are often controversial. The first BSL-4 lab in Japan was built in 1981, but operated with lower-risk pathogens until 2015, when safety concerns were finally overcome.
    And here's why all this is an issue:
    Worries surround the Chinese lab. The SARS virus has escaped from high-level containment facilities in Beijing multiple times, notes Richard Ebright, a molecular biologist at Rutgers University in Piscataway, New Jersey.
    Below we repost the full Nature article because it strongly hints, without evidence for now, that the coronavirus epidemic may well have been a weaponized virus which "accidentally" escaped the Wuhan biohazard facility.
    NEVER MISS THE NEWS THAT MATTERS MOST


    ZEROHEDGE DIRECTLY TO YOUR INBOX
    Receive a daily recap featuring a curated list of must-read stories.





    Inside the Chinese lab poised to study world's most dangerous pathogens
    A laboratory in Wuhan is on the cusp of being cleared to work with the world’s most dangerous pathogens. The move is part of a plan to build between five and seven biosafety level-4 (BSL-4) labs across the Chinese mainland by 2025, and has generated much excitement, as well as some concerns.
    Hazard suits hang at the National Bio-safety Laboratory, Wuhan, the first lab on the Chinese mainland equipped for the highest level of biocontainment. Some scientists outside China worry about pathogens escaping, and the addition of a biological dimension to geopolitical tensions between China and other nations. But Chinese microbiologists are celebrating their entrance to the elite cadre empowered to wrestle with the world’s greatest biological threats.
    “It will offer more opportunities for Chinese researchers, and our contribution on the BSL‑4-level pathogens will benefit the world,” says George Gao, director of the Chinese Academy of Sciences Key Laboratory of Pathogenic Microbiology and Immunology in Beijing. There are already two BSL-4 labs in Taiwan, but the National Bio-safety Laboratory, Wuhan, would be the first on the Chinese mainland.
    The lab was certified as meeting the standards and criteria of BSL-4 by the China National Accreditation Service for Conformity Assessment (CNAS) in January. The CNAS examined the lab’s infrastructure, equipment and management, says a CNAS representative, paving the way for the Ministry of Health to give its approval. A representative from the ministry says it will move slowly and cautiously; if the assessment goes smoothly, it could approve the laboratory by the end of June.
    BSL-4 is the highest level of biocontainment: its criteria include filtering air and treating water and waste before they leave the laboratory, and stipulating that researchers change clothes and shower before and after using lab facilities. Such labs are often controversial. The first BSL-4 lab in Japan was built in 1981, but operated with lower-risk pathogens until 2015, when safety concerns were finally overcome.
    The expansion of BSL-4-lab networks in the United States and Europe over the past 15 years — with more than a dozen now in operation or under construction in each region — also met with resistance, including questions about the need for so many facilities.
    The Wuhan lab cost 300 million yuan (US$44 million), and to allay safety concerns it was built far above the flood plain and with the capacity to withstand a magnitude-7 earthquake, although the area has no history of strong earthquakes. It will focus on the control of emerging diseases, store purified viruses and act as a World Health Organization ‘reference laboratory’ linked to similar labs around the world. “It will be a key node in the global biosafety-lab network,” says lab director Yuan Zhiming.
    The Chinese Academy of Sciences approved the construction of a BSL-4 laboratory in 2003, and the epidemic of SARS (severe acute respiratory syndrome) around the same time lent the project momentum. The lab was designed and constructed with French assistance as part of a 2004 cooperative agreement on the prevention and control of emerging infectious diseases. But the complexity of the project, China’s lack of experience, difficulty in maintaining funding and long government approval procedures meant that construction wasn’t finished until the end of 2014.
    The lab’s first project will be to study the BSL-3 pathogen that causes Crimean–Congo haemorrhagic fever: a deadly tick-borne virus that affects livestock across the world, including in northwest China, and that can jump to people.
    Future plans include studying the pathogen that causes SARS, which also doesn’t require a BSL-4 lab, before moving on to Ebola and the West African Lassa virus, which do. Some one million Chinese people work in Africa; the country needs to be ready for any eventuality, says Yuan. “Viruses don’t know borders.”
    Gao travelled to Sierra Leone during the recent Ebola outbreak, allowing his team to report the speed with which the virus mutated into new strains. The Wuhan lab will give his group a chance to study how such viruses cause disease, and to develop treatments based on antibodies and small molecules, he says.
    The opportunities for international collaboration, meanwhile, will aid the genetic analysis and epidemiology of emergent diseases. “The world is facing more new emerging viruses, and we need more contribution from China,” says Gao. In particular, the emergence of zoonotic viruses — those that jump to humans from animals, such as SARS or Ebola — is a concern, says Bruno Lina, director of the VirPath virology lab in Lyon, France.
    Many staff from the Wuhan lab have been training at a BSL-4 lab in Lyon, which some scientists find reassuring. And the facility has already carried out a test-run using a low-risk virus.
    But worries surround the Chinese lab, too. The SARS virus has escaped from high-level containment facilities in Beijing multiple times, notes Richard Ebright, a molecular biologist at Rutgers University in Piscataway, New Jersey. Tim Trevan, founder of CHROME Biosafety and Biosecurity Consulting in Damascus, Maryland, says that an open culture is important to keeping BSL-4 labs safe, and he questions how easy this will be in China, where society emphasizes hierarchy. “Diversity of viewpoint, flat structures where everyone feels free to speak up and openness of information are important,” he says.
    Yuan says that he has worked to address this issue with staff. “We tell them the most important thing is that they report what they have or haven’t done,” he says. And the lab’s inter*national collaborations will increase openness. “Transparency is the basis of the lab,” he adds.
    The plan to expand into a network heightens such concerns. One BSL-4 lab in Harbin is already awaiting accreditation; the next two are expected to be in Beijing and Kunming, the latter focused on using monkey models to study disease.
    Lina says that China’s size justifies this scale, and that the opportunity to combine BSL-4 research with an abundance of research monkeys — Chinese researchers face less red tape than those in the West when it comes to research on primates — could be powerful. “If you want to test vaccines or antivirals, you need a non-human primate model,” says Lina.
    But Ebright is not convinced of the need for more than one BSL-4 lab in mainland China. He suspects that the expansion there is a reaction to the networks in the United States and Europe, which he says are also unwarranted. He adds that governments will assume that such excess capacity is for the potential development of bioweapons.
    “These facilities are inherently dual use,” he says. The prospect of ramping up opportunities to inject monkeys with pathogens also worries, rather than excites, him: “They can run, they can scratch, they can bite.”
    The central monitor room at China’s National Bio-safety Laboratory
    If that wasn't enough, here is January 2018 press release from the Wuhan Institute of Virology, announcing the launch of the "top-level biosafety lab."
    China has put its first level-four biosafety laboratory into operation, capable of conducting experiments with highly pathogenic microorganisms that can cause fatal diseases, according to the national health authority. Level four is the highest biosafety level, used for diagnostic work and research on easily transmitted pathogens that can cause fatal diseases, including the Ebola virus.
    The Wuhan national level-four biosafety lab recently passed an assessment organized by the National Health and Family Planning Commission, according to a news release on Friday from the Wuhan Institute of Virology of the Chinese Academy of Sciences.
    Virologists read data on a container for viral samples at China's first level-four biosafety lab at the Institute of Virology in Wuhan After evaluating such things as the lab's management of personnel, facilities, animals, disposals and viruses, experts believed the lab is qualified to carry out experiments on highly pathogenic microorganisms that can cause fatal diseases, such as Marburg, Variola, Nipah and Ebola.
    "The lab provides a complete, world-leading biosafety system. This means Chinese scientists can study the most dangerous pathogenic microorganisms in their own lab," the Wuhan institute said.
    It will serve as the country's research and development center on prevention and control of infectious diseases, as a pathogen collection center and as the United Nations' reference laboratory for infectious diseases, the institute said.
    Previous media reports said the Wuhan P4 lab will be open to scientists from home and abroad. Scientists can conduct research on anti-virus drugs and vaccines in the lab.
    The lab is part of Sino-French cooperation in the prevention and control of emerging infectious diseases, according to the news release.
    The central government approved the P4 laboratory in 2003 when the outbreak of severe acute respiratory syndrome spread alarm across the country. In October 2004, China signed a cooperation agreement with France on the prevention and control of emerging infectious diseases. This was followed by a succession of supplementary agreements.
    With French assistance in laboratory design, biosafety standards establishment and personnel training, construction began in 2011 and lasted for three years. In 2015, the lab was put into trial operation.
    Finally, this is what the real Umbrella Corp looks like from space:

    https://www.zerohedge.com/economics/...rous-pathogens
    Europe used to have empires. They were run by emperors.
    Then we had kingdoms. They were run by kings.
    Now we have countries...

  2. #2
    Join Date
    Apr 2017
    Posts
    2,490

    Default



    Bioweapon ?

    If it is gene targeted, it might be an ethnic bioweapon.


  3. #3
    Join Date
    Oct 2008
    Location
    The Sanctuary
    Posts
    12,723

    Default

    The Chinese created a bio-weapon to kill Chinese?
    Pastor Guest

    Free E- Book!

    "Steps Toward the Mark of the Beast"
    The Christian's Guide to the How and Why of
    the Coming Cashless/RFID Economic System


  4. #4
    Join Date
    Aug 2010
    Posts
    993

    Default

    Actually, they stole it from the Canadians

    https://vladtepesblog.com/2020/01/22/corona-virus-developed-in-canada-and-stolen-by-china-links-2-january-22-2020

    "Corona virus. A Canadian made pathogen weaponized and leaked by China and named after a Mexican beer. That, is multiculturalism."
    ​HAVE A PLAN TO KILL EVERYONE YOU MEET



  5. #5
    Join Date
    Apr 2017
    Posts
    2,490

    Default

    Quote Originally Posted by Pastor Guest View Post


    The Chinese created a bio-weapon to kill Chinese?



    China also has ethnic minorities.

    China's decades long 'one child policy' [and forced abortion] targeted the Han [ethnic Chinese]... ethnic minorities were exempt.

    Chinese leader Deng Xiaoping who decreed China's one-child policy was born in a Hakka region. The "Hakka" [word means "guests"] are figuratively and literally associated with Jews. The Hakkas were foreigners who appeared in China in the Song Dynasty which began in 960AD [10th century] around the same time the Khazar Empire was destroyed by Sviatoslav I of Kievan Rus.


  6. #6
    Join Date
    Apr 2017
    Posts
    2,490

    Default



    Event 201
    http://www.centerforhealthsecurity.org/event201/



    A 'High-Level Exercise' Conducted 3 Months Ago Showed That A Coronavirus Pandemic Could Kill 65 Million People


    January 24, 2020

    by Michael Snyder

    " Just over three months ago, a "high-level pandemic exercise" entitled "Event 201" was held in New York City. On October 18th the Johns Hopkins Center for Health Security, in conjunction with the World Economic Forum and the Bill & Melinda Gates Foundation, brought together "15 leaders of business, government, and public health" to simulate a scenario in which a coronavirus pandemic was ravaging the planet. The current coronavirus outbreak that originated in China did not begin until December, and so at that time it was supposedly just a hypothetical exercise. The following comes from the official page for this event... "

    More at link

    https://www.investmentwatchblog.com/...illion-people/


    Event 201

    About the Event 201 exercise

    Event 201 was a 3.5-hour pandemic tabletop exercise that simulated a series of dramatic, scenario-based facilitated discussions, confronting difficult, true-to-life dilemmas associated with response to a hypothetical, but scientifically plausible, pandemic. 15 global business, government, and public health leaders were players in the simulation exercise that highlighted unresolved real-world policy and economic issues that could be solved with sufficient political will, financial investment, and attention now and in the future.

    The exercise consisted of pre-recorded news broadcasts, live "staff" briefings, and moderated discussions on specific topics. These issues were carefully designed in a compelling narrative that educated the participants and the audience.

    The Johns Hopkins Center for Health Security, World Economic Forum, and Bill & Melinda Gates Foundation jointly propose these recommendations.


    Purpose

    In recent years, the world has seen a growing number of epidemic events, amounting to approximately 200 events annually. These events are increasing, and they are disruptive to health, economies, and society. Managing these events already strains global capacity, even absent a pandemic threat. Experts agree that it is only a matter of time before one of these epidemics becomes global-a pandemic with potentially catastrophic consequences. A severe pandemic, which becomes "Event 201," would require reliable cooperation among several industries, national governments, and key international institutions.

    Recent economic studies show that pandemics will be the cause of an average annual economic loss of 0.7% of global GDP - or $570 billion. The players responses to the scenario illuminated the need for cooperation among industry, national governments, key international institutions, and civil society, to avoid the catastrophic consequences that could arise from a large-scale pandemic.

    Similar to the Center's 3 previous exercises - Clade X, Dark Winter, and Atlantic Storm-Event 201 aimed to educate senior leaders at the highest level of US and international governments and leaders in global industries.

    It is also a tool to inform members of the policy and preparedness communities and the general public. This is distinct from many other forms of simulation exercises that test protocols or technical policies of a specific organization. Exercises similar to Event 201 are a particularly effective way to help policymakers gain a fuller understanding of the urgent challenges they could face in a dynamic, real-world crisis.


    Scenario

    Details about the scenario are available here.

    http://www.centerforhealthsecurity.o.../scenario.html


    Recommendations

    The next severe pandemic will not only cause great illness and loss of life but could also trigger major cascading economic and societal consequences that could contribute greatly to global impact and suffering. The Event 201 pandemic exercise, conducted on October 18, 2019, vividly demonstrated a number of these important gaps in pandemic preparedness as well as some of the elements of the solutions between the public and private sectors that will be needed to fill them. The Johns Hopkins Center for Health Security, World Economic Forum, and Bill & Melinda Gates Foundation jointly propose these recommendations.


    When/where

    Friday, October 18, 2019
    8:45 a.m. 12:30 p.m.
    The Pierre hotel
    New York, NY
    Audience

    An invitation-only audience of nearly 130 people attended the exercises, and a livestream of the event was available to everyone. Video coverage is available here.


    Exercise team

    Eric Toner, MD, is the exercise team lead from the Johns Hopkins Center for Health Security. Crystal Watson, DrPH, MPH and Tara Kirk Sell, PhD, MA are co-leads from the Johns Hopkins Center for Health Security. Ryan Morhard, JD, is the exercise lead from the World Economic Forum, and Jeffrey French is the exercise lead for the Bill and Melinda Gates Foundation.

    Exercise team members are Tom Inglesby, MD; Anita Cicero, JD; Randy Larsen, USAF (retired); Caitlin Rivers, PhD, MPH; Diane Meyer, RN, MPH; Matthew Shearer, MPH; Matthew Watson; Richard Bruns, PhD; Jackie Fox; Andrea Lapp; Margaret Miller; Carol Miller; and Julia Cizek.

    Event 201 was supported by funding from the Open Philanthropy Project.

    http://www.centerforhealthsecurity.org/event201/about


    The Event 201 scenario

    Event 201 simulates an outbreak of a novel zoonotic coronavirus transmitted from bats to pigs to people that eventually becomes efficiently transmissible from person to person, leading to a severe pandemic. The pathogen and the disease it causes are modeled largely on SARS, but it is more transmissible in the community setting by people with mild symptoms.

    The disease starts in pig farms in Brazil, quietly and slowly at first, but then it starts to spread more rapidly in healthcare settings. When it starts to spread efficiently from person to person in the low-income, densely packed neighborhoods of some of the megacities in South America, the epidemic explodes. It is first exported by air travel to Portugal, the United States, and China and then to many other countries. Although at first some countries are able to control it, it continues to spread and be reintroduced, and eventually no country can maintain control.

    There is no possibility of a vaccine being available in the first year. There is a fictional antiviral drug that can help the sick but not significantly limit spread of the disease.

    Since the whole human population is susceptible, during the initial months of the pandemic, the cumulative number of cases increases exponentially, doubling every week. And as the cases and deaths accumulate, the economic and societal consequences become increasingly severe.

    The scenario ends at the 18-month point, with 65 million deaths. The pandemic is beginning to slow due to the decreasing number of susceptible people. The pandemic will continue at some rate until there is an effective vaccine or until 80-90 % of the global population has been exposed. From that point on, it is likely to be an endemic childhood disease.

    http://www.centerforhealthsecurity.o.../scenario.html


    More Event 201 info at link

    http://www.centerforhealthsecurity.org/event201/




Posting Permissions

  • You may not post new threads
  • You may not post replies
  • You may not post attachments
  • You may not edit your posts
  •